CYTOMEDIX INC (CTF) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 29 transactions totaling $1.7M, demonstrating a bullish sentiment with $1.7M in net insider flow. The most recent transaction on Dec 8, 2016 involved a purchase of 1,267 shares valued at $16.6K.
No significant insider buying has been recorded for CTF in the recent period.
No significant insider selling has been recorded for CTF in the recent period.
Based on recent SEC filings, insider sentiment for CTF is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CYTOMEDIX INC (CTF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading CTF stock, having executed 29 transactions in the past 90 days. The most active insider is Andrew Dakos (Executive), who has made 11 transactions totaling $506.1K.
Get notified when executives and directors at CTF file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 8, 2016 | Goldstein Phillip | Executive | Purchase | 1,267 | $13.13 | $16.6K | |
| Dec 6, 2016 | Samuels Steven | Executive | Purchase | 1,327 | $13.13 | $17.4K | |
| Dec 5, 2016 | Llc Bulldog Investors, | Executive | Purchase | 1,940 | $13.28 | $25.8K | |
| Dec 2, 2016 | Llc Bulldog Investors, | Executive | Purchase | 8,890 | $13.18 | $117.2K | |
| Dec 1, 2016 | Dakos Andrew | Executive | Purchase | 6,377 | $13.08 | $83.4K | |
| Nov 30, 2016 | Dakos Andrew | Executive | Purchase | 1,802 | $13.06 | $23.5K | |
| Nov 29, 2016 | Goldstein Phillip | Executive | Purchase | 4,230 | $12.88 | $54.5K | |
| Nov 28, 2016 | Goldstein Phillip | Executive | Purchase | 7,848 | $12.99 | $101.9K | |
| Nov 23, 2016 | Samuels Steven | Executive | Purchase | 7,635 | $13.05 | $99.6K | |
| Nov 22, 2016 | Dakos Andrew | Executive | Purchase | 3,478 | $13.05 | $45.4K | |
| Nov 21, 2016 | Dakos Andrew | Executive | Purchase | 1,877 | $13.00 | $24.4K | |
| Nov 17, 2016 | Dakos Andrew | Executive | Purchase | 1,704 | $12.90 | $22.0K | |
| Nov 15, 2016 | Goldstein Phillip | Executive | Purchase | 1,950 | $12.86 | $25.1K | |
| Nov 14, 2016 | Goldstein Phillip | Executive | Purchase | 7,434 | $12.88 | $95.7K | |
| Nov 10, 2016 | Samuels Steven | Executive | Purchase | 10,274 | $13.06 | $134.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 29 | $1.7M | 100.0% |
Insiders at CYTOMEDIX INC are accumulating shares at an accelerated pace. With 8 insiders making 29 transactions totaling $1.7M in purchases versus $0 in sales, the net buying activity of $1.7M signals strong executive confidence. Andrew Dakos (Executive) leads the buying activity with $506.1K in transactions across all time.